A Fast-Growing, Global Innovator of
Bone and Joint Restoration Products
- Apr 21, 2014 Exactech Q1 Revenue Up 7% to $63.3 Million. Net Income up 9% to $4.2 Million. Diluted EPS $0.30 vs. $0.29.
- Exactech's collaborative relationships with surgeons serve the interests of patients and meet high ethical standards. View our code of ethics, hotline, and details about our consultants here.